Maravai LifeSciences appoints Bernd Brust as CEO, succeeding William Martin

MARAVAI LIFESCIENCES HOLDINGS, INC.

Bernd Brust named CEO and board member effective June 8, 2025; William Martin resigned as CEO and from board.
Brust's base salary is $750,000 with a target annual cash bonus of 100% of base salary.
Equity awards: 1M stock options, 2M RSUs, 2.25M PSUs; options and RSUs vest over three years.
Martin's departure not due to any disagreement; he is eligible for severance per existing agreement.
Company will revisit FY2025 guidance in August Q2 earnings call after Brust's assessment.

item 5.02item 7.01item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

William E. Martin, III

Director

MRVI · MARAVAI LIFESCIENCES HOLDINGS, INC.

Effective: 2025-06-08
Filed: Jun 09, 2025 23:59 UTC

Mr. Martin resigned from the Board

Appointed

Bernd Brust

Director

MRVI · MARAVAI LIFESCIENCES HOLDINGS, INC.

Effective: 2025-06-08
Filed: Jun 09, 2025 23:59 UTC

Mr. Brust was appointed as a member of the Board

Source: SEC EDGAR

accession 0001193125-25-137478

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.